Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Wondercel Therapeutics

Explore full profile

Developing next-generation allogeneic CAR-T and immune-tolerance cell therapies

Shenzhen, ChinaFounded 2022
Valuation $100–250M Last recorded · 2026
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Wondercel Therapeutics and the history behind them.

About Wondercel Therapeutics

Wondercel Therapeutics, legally Shenzhen Bay Island Cell Technology Co., Ltd., is a Shenzhen biotechnology company developing next-generation immune-cell therapies for malignant tumors, organ transplantation, and autoimmune diseases. Founded on August 1, 2022 by Dr. Xiaohu Fan, the company is building the REVO-U gene-editing-free allogeneic CAR-T platform, designed for off-the-shelf manufacturing with modular multi-target programs. Its pipeline spans hematologic malignancies and solid tumors, including CD19, BCMA, GUCY2C, and GPC3 programs, alongside an induced regulatory T-cell (iTreg) platform intended to reduce immunosuppression after transplantation. Wondercel's programs are investigational and are being advanced from Shenzhen through collaboration across industry, academia, research institutions, and hospitals.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2022
Headquarters
Shenzhen, China
Open positions
None listed
Dealroom signal
18.1/100

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jul 2026 $19M $77M Cowin Capital · Oriental Fortune Capital ↗
EARLY VC✓Equity / VC Feb 2023 $14M $56M Yuansheng Venture Capital ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Yuansheng Venture Capital
  • Cowin Capital
  • Oriental Fortune Capital

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Shenzhen HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Wondercel Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Wondercel Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.